Clinical Trials
8 trialsNCT00198315 2022-03-04
Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma
Inovio Pharmaceuticals
Phase 3 Terminated
NCT00198328 2022-03-04
Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma
Inovio Pharmaceuticals
Phase 3 Terminated
NCT01606566 2022-02-18
A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.
PCI Biotech AS
Phase 2 Terminated
NCT00993512 2019-04-29
Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer
PCI Biotech AS
Phase 1 Completed
NCT00198263 2017-10-03
Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer
Inovio Pharmaceuticals
Phase 4 Completed
NCT02549742 2017-01-18
Electrochemotherapy on Head and Neck Cancer
Rigshospitalet, Denmark
Phase 2 Unknown
NCT01872923 2014-06-16
Dose Escalating Study for Amphinex-based PCI of Bleomycin.
PCI Biotech AS
Phase 1 Completed
NCT00002476 2013-08-02
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
National Cancer Institute (NCI)
Phase 3 Completed